Free Trial
OTCMKTS:PBIO

Pressure BioSciences 2/7/2025 Earnings Report

Pressure BioSciences logo
$0.0003 0.00 (0.00%)
As of 09/19/2025

Pressure BioSciences EPS Results

Actual EPS
-$0.15
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Pressure BioSciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Pressure BioSciences Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Pressure BioSciences Earnings Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
The big blood pressure experiment
See More Pressure BioSciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pressure BioSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pressure BioSciences and other key companies, straight to your email.

About Pressure BioSciences

Pressure BioSciences (OTCMKTS:PBIO), Inc., headquartered in South Easton, Massachusetts, develops and markets novel pressure-based instruments and consumables for sample preparation in the life sciences, biotechnology and pharmaceutical industries. The company’s core innovation, Pressure Cycling Technology (PCT), uses alternating cycles of high hydrostatic pressure to facilitate efficient and reproducible cell disruption, protein extraction and subcellular fractionation. Its flagship Barocycler® instrument has been adopted by researchers working in proteomics, biomarker discovery, vaccine development and pathogen inactivation workflows.

In addition to its instrument platform, Pressure BioSciences offers a range of proprietary consumables—including pressure-resistant processing tubes and optimized reagent kits—designed to support diverse sample types such as tissue, microbes and blood derivatives. The company also markets an Ultra Shear Technology (UST) system for high-pressure homogenization, targeting applications in food science, nutraceutical development and personal care product formulation.

Pressure BioSciences serves a global customer base through direct sales and distribution partners in North America, Europe and Asia. Its clients include academic and government research institutions, contract research organizations and biotechnology and pharmaceutical companies. Although it operates as a small-cap public company on the OTC markets, the firm has established collaborative relationships with leading research centers and regularly showcases its sample-preparation solutions at scientific conferences and trade exhibitions.

View Pressure BioSciences Profile

More Earnings Resources from MarketBeat